Eli Lilly and Company has chosen the Lehigh Valley in Pennsylvania for its next manufacturing site in a $3.5 billion ...
Libris Innovations, the for-profit subsidiary of the Indiana Biosciences Research Institute (IBRI), has appointed Ramani ...
Merz Therapeutics has appointed Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Staner will ...
Ardena has completed the process of divesting its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.
Expansions in the US and Europe are included in a €1.5 billion investment plan ...
In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results